Pages with the fewest revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Showing below up to 250 results in range #1 to #250.

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)

  1. Interleukin 29‏‎ (1 revision)
  2. Low motivation‏‎ (1 revision)
  3. Plant-based diet‏‎ (1 revision)
  4. Light-headedness‏‎ (1 revision)
  5. WellnessFX‏‎ (1 revision)
  6. Maca‏‎ (1 revision)
  7. Croatia‏‎ (1 revision)
  8. Granulocyte‏‎ (1 revision)
  9. LiveWello‏‎ (1 revision)
  10. Portal:Heart‏‎ (1 revision)
  11. Very severe ME/CFS‏‎ (1 revision)
  12. Interleukin 9‏‎ (1 revision)
  13. International Classification of Diseases‏‎ (1 revision)
  14. L-form bacteria‏‎ (1 revision)
  15. Beta 2-adrenergic receptor‏‎ (1 revision)
  16. Misophonia‏‎ (1 revision)
  17. Night sweat‏‎ (1 revision)
  18. Nocturia‏‎ (1 revision)
  19. Interleukin 11‏‎ (1 revision)
  20. Interleukin 12‏‎ (1 revision)
  21. Lithuania‏‎ (1 revision)
  22. Wikiagency Ltd‏‎ (1 revision)
  23. Multi-tasking problems‏‎ (1 revision)
  24. Interleukin 23‏‎ (1 revision)
  25. Interleukin 5‏‎ (1 revision)
  26. Endocannabinoid‏‎ (1 revision)
  27. Interleukin 28‏‎ (1 revision)
  28. Planning problems‏‎ (1 revision)
  29. Joseph Cotler‏‎ (1 revision)
  30. Lower back pain‏‎ (1 revision)
  31. Organic anion transporting polypeptide 1B1‏‎ (1 revision)
  32. Why am I So Exhausted? understanding Chronic Fatigue Syndrome‏‎ (1 revision)
  33. Orientation in space problems‏‎ (1 revision)
  34. Venezuela‏‎ (1 revision)
  35. ME-föreningen‏‎ (1 revision)
  36. Cimetidine‏‎ (1 revision)
  37. Adalimumab‏‎ (1 revision)
  38. Fingolimod‏‎ (1 revision)
  39. Oxfordshire ME Group for Action‏‎ (1 revision)
  40. Parkinson's disease‏‎ (1 revision)
  41. Extension:TemplateData‏‎ (1 revision)
  42. Know Your Genetics‏‎ (1 revision)
  43. BBC‏‎ (1 revision)
  44. Blood pressure‏‎ (1 revision)
  45. Interleukin 15‏‎ (1 revision)
  46. French Guiana‏‎ (1 revision)
  47. ICP‏‎ (1 revision)
  48. Jamison Writes‏‎ (1 revision)
  49. Severe ME/CFS‏‎ (1 revision)
  50. Tension-type headache‏‎ (1 revision)
  51. SpO2‏‎ (1 revision)
  52. MTHFR.net‏‎ (1 revision)
  53. Portal:Brain/Selected article/5‏‎ (1 revision)
  54. Sciatica‏‎ (1 revision)
  55. Brainfogforgotpw‏‎ (1 revision)
  56. Leaky brain‏‎ (1 revision)
  57. Seborrheic dermatitis‏‎ (1 revision)
  58. Difficulty comprehending social cues‏‎ (1 revision)
  59. Clostridium‏‎ (1 revision)
  60. Murphy‏‎ (2 revisions)
  61. Receptive language problems‏‎ (2 revisions)
  62. Data:I18n/Template/Graph:Lines.tab‏‎ (2 revisions)
  63. Anne Cooke‏‎ (2 revisions)
  64. Is This Why You're Still So Tired? - Oprah.com: Health and Wellness (2015)‏‎ (2 revisions)
  65. Hypothalamic-pituitary-gonadal axis‏‎ (2 revisions)
  66. Paolo Bolognese‏‎ (2 revisions)
  67. Editorial Guidelines‏‎ (2 revisions)
  68. Immunoglobulin D‏‎ (2 revisions)
  69. Peter Tarbleton‏‎ (2 revisions)
  70. Itraconazole‏‎ (2 revisions)
  71. Ranitidine‏‎ (2 revisions)
  72. Science Guidelines‏‎ (2 revisions)
  73. List of symptoms in ME CFS/ICC/Neurological/NSP‏‎ (2 revisions)
  74. NIH intramural study of ME/CFS‏‎ (2 revisions)
  75. Eoxins‏‎ (2 revisions)
  76. Esther Rantzen‏‎ (2 revisions)
  77. JOGO‏‎ (2 revisions)
  78. ME The Hidden Truth‏‎ (2 revisions)
  79. Meclizine‏‎ (2 revisions)
  80. Millions Missing France‏‎ (2 revisions)
  81. Metabolic detoxification‏‎ (2 revisions)
  82. Nicola Clague-Baker‏‎ (2 revisions)
  83. Vitamin B12 deficiency‏‎ (2 revisions)
  84. Bolivia‏‎ (2 revisions)
  85. Talking therapy‏‎ (2 revisions)
  86. Guyana‏‎ (2 revisions)
  87. Interleukin 1 alpha‏‎ (2 revisions)
  88. Peru‏‎ (2 revisions)
  89. Greg Emerson‏‎ (2 revisions)
  90. Beth Pollack‏‎ (2 revisions)
  91. FlaviNOx‏‎ (2 revisions)
  92. OMEGA‏‎ (2 revisions)
  93. Nice guidelines‏‎ (2 revisions)
  94. ACT ME/Chronic Fatigue Syndrome Society‏‎ (2 revisions)
  95. Human growth hormone‏‎ (2 revisions)
  96. Psychoneuroimmunology‏‎ (2 revisions)
  97. Skin itch‏‎ (2 revisions)
  98. Platelet‏‎ (2 revisions)
  99. Receptor for advanced glycosylation end-product‏‎ (2 revisions)
  100. Seabiscuit‏‎ (2 revisions)
  101. Melanocyte-stimulating hormone‏‎ (2 revisions)
  102. See Ampligen Exercise Tolerance - graph 1‏‎ (2 revisions)
  103. Pyruvate dehydrogenase kinase‏‎ (2 revisions)
  104. Svetlana Orlova‏‎ (2 revisions)
  105. Portal:Brain/Selected article‏‎ (2 revisions)
  106. GRADE framework‏‎ (2 revisions)
  107. Pericarditis‏‎ (2 revisions)
  108. Portal:Heart/Intro‏‎ (2 revisions)
  109. Estonia‏‎ (2 revisions)
  110. Neuron‏‎ (2 revisions)
  111. OL (identifier)‏‎ (2 revisions)
  112. Tetrahydrobiopterin‏‎ (2 revisions)
  113. Interferon kappa‏‎ (2 revisions)
  114. Visible‏‎ (2 revisions)
  115. Resolvin‏‎ (2 revisions)
  116. CoCure mailing list‏‎ (2 revisions)
  117. Interleukin 3‏‎ (2 revisions)
  118. Journal of Nuclear Medicine‏‎ (2 revisions)
  119. OMF's Repository‏‎ (2 revisions)
  120. The ME Society of America‏‎ (2 revisions)
  121. Peter Marshall‏‎ (2 revisions)
  122. The Clinical and Scientific Basis of Myalgic Encephalomyelitis--Chronic Fatigue Syndrome‏‎ (2 revisions)
  123. CH3Nutrigenomics‏‎ (2 revisions)
  124. Olive leaf and olives‏‎ (2 revisions)
  125. Basophil‏‎ (2 revisions)
  126. Rag and Bone Shop of the Heart: E.M. and M.E.‏‎ (2 revisions)
  127. Methyl donor‏‎ (2 revisions)
  128. Wild Horses‏‎ (2 revisions)
  129. ME/CFS Collaborative Research Center at Stanford‏‎ (2 revisions)
  130. The matzah ball‏‎ (2 revisions)
  131. Audiovisual stimulation‏‎ (2 revisions)
  132. Epimedium‏‎ (2 revisions)
  133. Neuromodulation‏‎ (2 revisions)
  134. SFC-SQM Madrid‏‎ (2 revisions)
  135. Computed tomography scan‏‎ (2 revisions)
  136. Executive function problems‏‎ (2 revisions)
  137. Multisystemic dyshomeostasis‏‎ (2 revisions)
  138. Giorgos Sakkas‏‎ (2 revisions)
  139. Sierra Leone‏‎ (2 revisions)
  140. Glutamate excitotoxicity‏‎ (2 revisions)
  141. ME Association of South Africa‏‎ (2 revisions)
  142. Ecuador‏‎ (2 revisions)
  143. Emergency room‏‎ (2 revisions)
  144. International Research Symposium - Emerge Australia‏‎ (2 revisions)
  145. Global Advocates for Myalgic Encephalomyelitis‏‎ (2 revisions)
  146. ME/CFS Forums‏‎ (2 revisions)
  147. Chronic fatigue syndrome recognized at last - San Francisco Chronicle (2015)‏‎ (2 revisions)
  148. Bloating‏‎ (2 revisions)
  149. Ville Valtonen‏‎ (2 revisions)
  150. Doctors with M.E.‏‎ (2 revisions)
  151. Interleukin 13‏‎ (2 revisions)
  152. Brain inflammation‏‎ (2 revisions)
  153. Suriname‏‎ (2 revisions)
  154. Hypertension‏‎ (2 revisions)
  155. Nuclear receptor subfamily 3 group C member 1 glucocorticoid‏‎ (2 revisions)
  156. Human papillomavirus‏‎ (2 revisions)
  157. ME/CFS Medical Education Campaign‏‎ (2 revisions)
  158. Sulfasalazine‏‎ (2 revisions)
  159. Wiskott-Aldrich Syndrome Protein Family Member 3‏‎ (2 revisions)
  160. Erythrocyte sedimentation rate‏‎ (3 revisions)
  161. Prolactin‏‎ (3 revisions)
  162. Beta defensin‏‎ (3 revisions)
  163. Azadirachta indica‏‎ (3 revisions)
  164. Secret files‏‎ (3 revisions)
  165. Mercury‏‎ (3 revisions)
  166. Campbell CFS/Fibromyalgia Rating Scale‏‎ (3 revisions)
  167. PTLT‏‎ (3 revisions)
  168. Jan Kimpen‏‎ (3 revisions)
  169. ME/CVS Vereniging‏‎ (3 revisions)
  170. Pancreas‏‎ (3 revisions)
  171. List of symptoms in ME CFS/Canadian/Digestive‏‎ (3 revisions)
  172. Goldenseal‏‎ (3 revisions)
  173. List of symptoms in ME CFS/Canadian/Urinary‏‎ (3 revisions)
  174. Loudy Priesterbach‏‎ (3 revisions)
  175. Blonde Voyage‏‎ (3 revisions)
  176. Pain catastrophizing‏‎ (3 revisions)
  177. Intracellular Injury Caused By Chronic Breathing Constriction‏‎ (3 revisions)
  178. Pleuritis‏‎ (3 revisions)
  179. Prostacyclin‏‎ (3 revisions)
  180. ME/CFS South Australia Inc‏‎ (3 revisions)
  181. Maja Stulemeijer‏‎ (3 revisions)
  182. RNase enzyme deficiency disease‏‎ (3 revisions)
  183. List of symptoms in ME CFS/Canadian/Sleep‏‎ (3 revisions)
  184. Quality of care‏‎ (3 revisions)
  185. Gotu kola‏‎ (3 revisions)
  186. Dmitry Maltsev‏‎ (3 revisions)
  187. Anorexia‏‎ (3 revisions)
  188. Paul van Meerendonk‏‎ (3 revisions)
  189. Hope for Chronic Fatigue Syndrome - Slate: Medical Examiner (2015)‏‎ (3 revisions)
  190. Paraguay‏‎ (3 revisions)
  191. Mangosteen‏‎ (3 revisions)
  192. Procaine‏‎ (3 revisions)
  193. Cholestyramine‏‎ (3 revisions)
  194. MEAction Scotland‏‎ (3 revisions)
  195. DNA Methylation‏‎ (3 revisions)
  196. ALA‏‎ (3 revisions)
  197. Private Members' Bills‏‎ (3 revisions)
  198. Chile‏‎ (3 revisions)
  199. Intracellular immune deregulations‏‎ (3 revisions)
  200. Famciclovir‏‎ (3 revisions)
  201. PubMed‏‎ (3 revisions)
  202. GcMAF‏‎ (3 revisions)
  203. Phillipe Bottello‏‎ (3 revisions)
  204. Bruce Hoffman‏‎ (3 revisions)
  205. Houston Chronicle‏‎ (3 revisions)
  206. I’m disabled. Can NIH spare a few dimes? - The Washington Post: To Your Health (2015)‏‎ (3 revisions)
  207. Russell Logan‏‎ (3 revisions)
  208. Colombia‏‎ (3 revisions)
  209. Korine Scheeres‏‎ (3 revisions)
  210. Patricia Zunszain‏‎ (3 revisions)
  211. Consequential Symptoms‏‎ (3 revisions)
  212. Millions Missing Canada‏‎ (3 revisions)
  213. Gram-negative bacteria‏‎ (3 revisions)
  214. Peroxisome proliferator activated receptor alpha‏‎ (3 revisions)
  215. Patient advocacy‏‎ (3 revisions)
  216. List of symptoms in ME CFS/Canadian/Respiratory‏‎ (3 revisions)
  217. Solute carrier organic anion transporter family member 1B1‏‎ (3 revisions)
  218. Parliament ME debate‏‎ (3 revisions)
  219. Intracranial compliance‏‎ (3 revisions)
  220. List of outbreaks:‏‎ (3 revisions)
  221. Pain management‏‎ (3 revisions)
  222. Antimycotics‏‎ (3 revisions)
  223. MDJunction‏‎ (3 revisions)
  224. Intestinal dysbiosis‏‎ (3 revisions)
  225. Methyl-CpG binding protein 2‏‎ (3 revisions)
  226. Robert Fredericks‏‎ (3 revisions)
  227. Marion Michell‏‎ (3 revisions)
  228. Prostanoid‏‎ (3 revisions)
  229. Difficulty thinking‏‎ (3 revisions)
  230. Constant F****** S***‏‎ (3 revisions)
  231. Polybio Research Foundation‏‎ (3 revisions)
  232. Quadram Institute‏‎ (3 revisions)
  233. Sigrid Hoogveld‏‎ (3 revisions)
  234. Alpha 2-adrenergic receptor‏‎ (3 revisions)
  235. Community Symposium on the Molecular Basis of ME/CFS‏‎ (3 revisions)
  236. Catecholamine‏‎ (3 revisions)
  237. Elise van de Putte‏‎ (3 revisions)
  238. Cerebral spinal fluid‏‎ (3 revisions)
  239. Salus Fatigue Foundation‏‎ (3 revisions)
  240. Brain Training‏‎ (3 revisions)
  241. Rowe‏‎ (3 revisions)
  242. ChronicallyME‏‎ (3 revisions)
  243. Remission Biome‏‎ (3 revisions)
  244. Ribavirin‏‎ (3 revisions)
  245. Iceland‏‎ (3 revisions)
  246. Markus Schwarz‏‎ (3 revisions)
  247. Auditory sequencing problems‏‎ (3 revisions)
  248. Lipoxins‏‎ (3 revisions)
  249. CFSGraphics‏‎ (3 revisions)
  250. Craniocervical fusion‏‎ (3 revisions)

View (previous 250 | ) (20 | 50 | 100 | 250 | 500)